Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.02.2022 | Case report

Dupilumab/triamcinolone/ustekinumab

Psoriasiform dermatitis, unmasking of psoriasis and lack of efficacy: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Parker JJ, et al. Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children. Pediatric Dermatology 38: 1500-1505, No. 6, Nov-Dec 2021. Available from: URL: http://doi.org/10.1111/pde.14820 Parker JJ, et al. Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children. Pediatric Dermatology 38: 1500-1505, No. 6, Nov-Dec 2021. Available from: URL: http://​doi.​org/​10.​1111/​pde.​14820
Metadaten
Titel
Dupilumab/triamcinolone/ustekinumab
Psoriasiform dermatitis, unmasking of psoriasis and lack of efficacy: 7 case reports
Publikationsdatum
01.02.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-10601-1

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Ponatinib

Case report

Lamotrigine

Case report

AZD-1222